Ankylosing spondylitis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Inspiratory Muscle Training in Axial Spondyloarthritis

  NCT07914439· Bursa Yuksek Ihtisas Training and Research Hospital· Source

• A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)

  NCT07133633· Merck Sharp & Dohme LLC· Source

• An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

  NCT06668181· UCB Biopharma SRL· Source

• Nurse-Led Exercise Program for Older Adults With Ankylosing Spondylitis

  NCT07891507· Mansoura University· Source

• A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission

  NCT05622708· Novartis Pharmaceuticals· Source

• An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment

  NCT04638647· Novartis Pharma AG· Source

• Taekwondo for Axial Spondyloarthritis

  NCT06823726· Wonju Severance Christian Hospital· Source

• A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

  NCT04436640· UCB Biopharma SRL· Source

• Optimizing treatment strategy in axial spondyloarthritis by molecular imaging with Technetium-labeled certolizumab pegol.

  2023-505694-32-00· Universitair Ziekenhuis Gent· Source

• A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

  NCT04527380· Eli Lilly and Company· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Mendelian Randomization Analysis 1
• Proteomics 1
• Metabolomics 1
• Cohort Studies 3
• Genome-Wide Association Study 1

See which targets of this disease your abstract mentions, and go to the people working on them.